White Papers

  1. Agentic AI And How It's Impacting Clinical Trial Research 7/7/2025

    Since ChatGPT’s launch in 2022, artificial intelligence has transformed industries worldwide—but the next evolution, Agentic AI, promises to be even more profound.

  2. Powering More Efficient Clinical Development With AI And ML 7/7/2025

    Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.

  3. Continuous Cough Monitoring: Addressing Placebo Effects And Data Gaps 7/7/2025

    Modernizing symptom monitoring is essential to improving clinical trial quality, and these tools deliver richer, more accurate data that can help close information gaps.

  4. eSource Purpose Is Not Just To Complete The EDC 7/7/2025

    Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.

  5. Expert Guidance For EU Gene Therapy And Companion Diagnostic Trial Regulations 6/27/2025

    This playbook provides a concise yet comprehensive roadmap for navigating Europe’s multifaceted regulatory environment when conducting gene therapy trials involving GMOs and CDx.

  6. Disclosure Management System: Build Or Buy? 6/19/2025

    Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

  7. Completed Clinical Trials Continued To Climb In 2024 6/19/2025

    Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.

  8. How Sponsors Can Drive Success With Central eSource At Investigator Sites 6/17/2025

    Centralized eSource systems enable complex clinical trials to align with key regulatory frameworks, including ICH E6(R3), ICH E8(R1), and 21 CFR 312, to meet the highest standards of GCP.

  9. Immunohistochemistry In Precision Medicine: From Biomarker To Clinical Trial Assay 6/17/2025

    From preclinical validation to clinical implementation, immunohistochemistry (IHC) is essential in understanding target biology and ensuring drug safety and efficacy.

  10. Leveraging AI To Transform Neurodegenerative Drug Development 6/11/2025

    Explore how AI is redefining the development pipeline for neurodegenerative diseases (NDDs), offering a path forward in the quest for effective, disease-modifying treatments.